Email
Print
Kidney Cancer Drugs Market - Forecast(2024 - 2030)
1. Kidney Cancer Drugs Market - Overview
1.1 Definitions and Scope
2. Kidney Cancer Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Kidney Cancer Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Kidney Cancer Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Kidney Cancer Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Kidney Cancer Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Kidney Cancer Drugs Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Kidney Cancer Drugs Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Angiogenesis Inhibitor
8.3.2 Immunotherapy
8.3.3 Monoclonal Antibody
8.3.4 Mtor Inhibitor
8.3.5 Generic
8.3.6 Other Product
9. Kidney Cancer Drugs Market - By Brand (Market Size -$Million / $Billion)
9.1 Afinitor
9.2 Avastin
9.3 Inlyta
9.4 Nexavar
9.5 Proleukin
9.6 Sutent
9.7 Torisel
9.8 Votrient
10. Kidney Cancer Drugs - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Kidney Cancer Drugs- By Geography (Market Size -$Million / $Billion)
11.1 Kidney Cancer Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Kidney Cancer Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Kidney Cancer Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Kidney Cancer Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Kidney Cancer Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Kidney Cancer Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Kidney Cancer Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Kidney Cancer Drugs Market - Key Company List by Country Premium
15. Kidney Cancer Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Active Biotech Ab
15.3 Amgen
15.4 Bayer Ag
15.5 Cipla Limited
15.6 F. Hoffmann-La Roche Ag
15.7 Genentech, Inc
15.8 Glaxosmithkline Plc
15.9 Novartis Ag
15.10 Onyx Pharmaceutical Inc
15.11 Pfizer Inc
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Kidney Cancer Drugs Market - Appendix
16.1 Abbreviations
16.2 Sources
17. Kidney Cancer Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 ($M)1.1 Angiogenesis Inhibitor Market 2019-2024 ($M) - Global Industry Research
1.3 Monoclonal Antibody Market 2019-2024 ($M) - Global Industry Research
1.4 Mtor Inhibitor Market 2019-2024 ($M) - Global Industry Research
1.5 Generic Market 2019-2024 ($M) - Global Industry Research
2.Global Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 ($M)
2.1 Afinitor Market 2019-2024 ($M) - Global Industry Research
2.2 Avastin Market 2019-2024 ($M) - Global Industry Research
2.3 Inlyta Market 2019-2024 ($M) - Global Industry Research
2.4 Nexavar Market 2019-2024 ($M) - Global Industry Research
2.5 Proleukin Market 2019-2024 ($M) - Global Industry Research
2.6 Sutent Market 2019-2024 ($M) - Global Industry Research
2.7 Torisel Market 2019-2024 ($M) - Global Industry Research
2.8 Votrient Market 2019-2024 ($M) - Global Industry Research
3.Global Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 (Volume/Units)
3.1 Angiogenesis Inhibitor Market 2019-2024 (Volume/Units) - Global Industry Research
3.3 Monoclonal Antibody Market 2019-2024 (Volume/Units) - Global Industry Research
3.4 Mtor Inhibitor Market 2019-2024 (Volume/Units) - Global Industry Research
3.5 Generic Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 (Volume/Units)
4.1 Afinitor Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Avastin Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Inlyta Market 2019-2024 (Volume/Units) - Global Industry Research
4.4 Nexavar Market 2019-2024 (Volume/Units) - Global Industry Research
4.5 Proleukin Market 2019-2024 (Volume/Units) - Global Industry Research
4.6 Sutent Market 2019-2024 (Volume/Units) - Global Industry Research
4.7 Torisel Market 2019-2024 (Volume/Units) - Global Industry Research
4.8 Votrient Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 ($M)
5.1 Angiogenesis Inhibitor Market 2019-2024 ($M) - Regional Industry Research
5.3 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
5.4 Mtor Inhibitor Market 2019-2024 ($M) - Regional Industry Research
5.5 Generic Market 2019-2024 ($M) - Regional Industry Research
6.North America Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 ($M)
6.1 Afinitor Market 2019-2024 ($M) - Regional Industry Research
6.2 Avastin Market 2019-2024 ($M) - Regional Industry Research
6.3 Inlyta Market 2019-2024 ($M) - Regional Industry Research
6.4 Nexavar Market 2019-2024 ($M) - Regional Industry Research
6.5 Proleukin Market 2019-2024 ($M) - Regional Industry Research
6.6 Sutent Market 2019-2024 ($M) - Regional Industry Research
6.7 Torisel Market 2019-2024 ($M) - Regional Industry Research
6.8 Votrient Market 2019-2024 ($M) - Regional Industry Research
7.South America Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 ($M)
7.1 Angiogenesis Inhibitor Market 2019-2024 ($M) - Regional Industry Research
7.3 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
7.4 Mtor Inhibitor Market 2019-2024 ($M) - Regional Industry Research
7.5 Generic Market 2019-2024 ($M) - Regional Industry Research
8.South America Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 ($M)
8.1 Afinitor Market 2019-2024 ($M) - Regional Industry Research
8.2 Avastin Market 2019-2024 ($M) - Regional Industry Research
8.3 Inlyta Market 2019-2024 ($M) - Regional Industry Research
8.4 Nexavar Market 2019-2024 ($M) - Regional Industry Research
8.5 Proleukin Market 2019-2024 ($M) - Regional Industry Research
8.6 Sutent Market 2019-2024 ($M) - Regional Industry Research
8.7 Torisel Market 2019-2024 ($M) - Regional Industry Research
8.8 Votrient Market 2019-2024 ($M) - Regional Industry Research
9.Europe Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 ($M)
9.1 Angiogenesis Inhibitor Market 2019-2024 ($M) - Regional Industry Research
9.3 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
9.4 Mtor Inhibitor Market 2019-2024 ($M) - Regional Industry Research
9.5 Generic Market 2019-2024 ($M) - Regional Industry Research
10.Europe Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 ($M)
10.1 Afinitor Market 2019-2024 ($M) - Regional Industry Research
10.2 Avastin Market 2019-2024 ($M) - Regional Industry Research
10.3 Inlyta Market 2019-2024 ($M) - Regional Industry Research
10.4 Nexavar Market 2019-2024 ($M) - Regional Industry Research
10.5 Proleukin Market 2019-2024 ($M) - Regional Industry Research
10.6 Sutent Market 2019-2024 ($M) - Regional Industry Research
10.7 Torisel Market 2019-2024 ($M) - Regional Industry Research
10.8 Votrient Market 2019-2024 ($M) - Regional Industry Research
11.APAC Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 ($M)
11.1 Angiogenesis Inhibitor Market 2019-2024 ($M) - Regional Industry Research
11.3 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
11.4 Mtor Inhibitor Market 2019-2024 ($M) - Regional Industry Research
11.5 Generic Market 2019-2024 ($M) - Regional Industry Research
12.APAC Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 ($M)
12.1 Afinitor Market 2019-2024 ($M) - Regional Industry Research
12.2 Avastin Market 2019-2024 ($M) - Regional Industry Research
12.3 Inlyta Market 2019-2024 ($M) - Regional Industry Research
12.4 Nexavar Market 2019-2024 ($M) - Regional Industry Research
12.5 Proleukin Market 2019-2024 ($M) - Regional Industry Research
12.6 Sutent Market 2019-2024 ($M) - Regional Industry Research
12.7 Torisel Market 2019-2024 ($M) - Regional Industry Research
12.8 Votrient Market 2019-2024 ($M) - Regional Industry Research
13.MENA Europe Kidney Cancer Drug Market, By Product Type Market 2019-2024 ($M)
13.1 Angiogenesis Inhibitor Market 2019-2024 ($M) - Regional Industry Research
13.3 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
13.4 Mtor Inhibitor Market 2019-2024 ($M) - Regional Industry Research
13.5 Generic Market 2019-2024 ($M) - Regional Industry Research
14.MENA Europe Kidney Cancer Drug Market, By Brand Market 2019-2024 ($M)
14.1 Afinitor Market 2019-2024 ($M) - Regional Industry Research
14.2 Avastin Market 2019-2024 ($M) - Regional Industry Research
14.3 Inlyta Market 2019-2024 ($M) - Regional Industry Research
14.4 Nexavar Market 2019-2024 ($M) - Regional Industry Research
14.5 Proleukin Market 2019-2024 ($M) - Regional Industry Research
14.6 Sutent Market 2019-2024 ($M) - Regional Industry Research
14.7 Torisel Market 2019-2024 ($M) - Regional Industry Research
14.8 Votrient Market 2019-2024 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)2.Canada Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
3.Mexico Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
4.Brazil Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
5.Argentina Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
6.Peru Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
7.Colombia Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
8.Chile Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
9.Rest of South America Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
10.UK Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
11.Germany Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
12.France Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
13.Italy Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
14.Spain Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
15.Rest of Europe Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
16.China Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
17.India Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
18.Japan Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
19.South Korea Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
20.South Africa Europe Kidney Cancer Drugs Market Revenue, 2019-2024 ($M)
21.North America Europe Kidney Cancer Drugs By Application
22.South America Europe Kidney Cancer Drugs By Application
23.Europe Europe Kidney Cancer Drugs By Application
24.APAC Europe Kidney Cancer Drugs By Application
25.MENA Europe Kidney Cancer Drugs By Application
26.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Onyx Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Bayer Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Active Biotech Ab, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Amgen, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Genentech, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Cipla Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)